Stroke:冠状动脉粥样硬化与脑白质高信号之间的关联

2021-05-20 MedSci原创 MedSci原创

在健康的高风险个体中,冠状动脉斑块的存在和体积与更大的WMH体积相关,对于PVWMH而言关联性最强。在高危家庭中的这些结果表明,除了传统的危险因素之外,可能是由于遗传易感性,介导了这两种不同血管床的疾

近日,血管疾病领域权威杂志Stroke上发表了一篇研究文章,研究人员旨在明确健康的高危成年人亚临床冠状动脉疾病与白质高信号(WMH)的数量和位置之间的关联,且与动脉粥样硬化的危险因素无关。

研究人员分析了来自动脉粥样硬化风险遗传学研究(GeneSTAR)研究早发型冠心病(<60岁)病例的782例无症状一级亲属,他们同时接受了冠状动脉计算机断层扫描血管造影和脑磁共振成像检查。

考虑到家庭结构,研究人员采用多级混合效应线性回归模型评估了总的WMH体积和3个区域(深部WMH、室周WMH [PVWMH]或边界带[cuff])与冠状动脉疾病标记之间的关联。研究人员为总WMH、深部WMH、PVWMH和cuff体积创建了单独的模型,并针对协变量进行了调整。

冠状动脉粥样硬化与脑白质高信号

受试者平均年龄为51±10岁,其中58%为女性,39%为非裔美国人。伴有冠状动脉斑块的参与者WMH量比无斑块的参与者大52%(95%CI为0.24-0.59)。冠状动脉斑块体积每增加1%,WMH总量就增加0.07%(95%CI为0.04-0.10)。当与深部WMH与PVWMH(相互作用P<0.001)或cuff体积(相互作用P<0.001)比较时,总冠状动脉斑块体积每增加1%,则深部WMH体积增大(5.0%)(95%CI为4.67–5.38),PVWMH体积增大5.10%(95%CI为4.72–5.48)和cuff体积增大2.74%(95%CI为2.38–3.09)。

由此可见,在健康的高风险个体中,冠状动脉斑块的存在和体积与更大的WMH体积相关,对于PVWMH而言关联性最强。在高危家庭中的这些结果表明,除了传统的危险因素之外,可能是由于遗传易感性,介导了这两种不同血管床的疾病关系。

原始出处:

Michelle C. Johansen.et al.Association of Coronary Artery Atherosclerosis With Brain White Matter Hyperintensity.stroke.2021.https://www.ahajournals.org/doi/10.1161/STROKEAHA.120.032674

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (6)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1222968, encodeId=b2561222968c8, content=<a href='/topic/show?id=98ba30898c7' target=_blank style='color:#2F92EE;'>#冠状动脉粥样硬化#</a>与<a href='/topic/show?id=7c4e84960c7' target=_blank style='color:#2F92EE;'>#脑白质#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=30898, encryptionId=98ba30898c7, topicName=冠状动脉粥样硬化), TopicDto(id=84960, encryptionId=7c4e84960c7, topicName=脑白质)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=清风徐来2022, createdTime=Sat May 28 11:36:30 CST 2022, time=2022-05-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1765865, encodeId=f79b1e6586522, content=<a href='/topic/show?id=252ae1803a3' target=_blank style='color:#2F92EE;'>#白质#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71803, encryptionId=252ae1803a3, topicName=白质)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=778d36, createdName=柳叶一刀, createdTime=Tue Sep 21 08:14:29 CST 2021, time=2021-09-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1944703, encodeId=82921944e0309, content=<a href='/topic/show?id=411de6300ad' target=_blank style='color:#2F92EE;'>#粥样硬化#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=76300, encryptionId=411de6300ad, topicName=粥样硬化)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b30d401, createdName=huangshifeng, createdTime=Wed Apr 20 08:14:29 CST 2022, time=2022-04-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1950828, encodeId=a5511950828b8, content=<a href='/topic/show?id=20101021e97e' target=_blank style='color:#2F92EE;'>#高信号#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=102179, encryptionId=20101021e97e, topicName=高信号)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=08e4137, createdName=meichuangyi, createdTime=Tue Jul 20 09:14:29 CST 2021, time=2021-07-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1417576, encodeId=3900141e576f0, content=<a href='/topic/show?id=c667e181616' target=_blank style='color:#2F92EE;'>#白质高信号#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71816, encryptionId=c667e181616, topicName=白质高信号)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=44693296090, createdName=zhangph, createdTime=Sat May 22 10:14:29 CST 2021, time=2021-05-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1506829, encodeId=f1541506829fc, content=<a href='/topic/show?id=a1af849e063' target=_blank style='color:#2F92EE;'>#脑白质高信号#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=84970, encryptionId=a1af849e063, topicName=脑白质高信号)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=79949824561, createdName=rgjl, createdTime=Sat May 22 10:14:29 CST 2021, time=2021-05-22, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1222968, encodeId=b2561222968c8, content=<a href='/topic/show?id=98ba30898c7' target=_blank style='color:#2F92EE;'>#冠状动脉粥样硬化#</a>与<a href='/topic/show?id=7c4e84960c7' target=_blank style='color:#2F92EE;'>#脑白质#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=30898, encryptionId=98ba30898c7, topicName=冠状动脉粥样硬化), TopicDto(id=84960, encryptionId=7c4e84960c7, topicName=脑白质)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=清风徐来2022, createdTime=Sat May 28 11:36:30 CST 2022, time=2022-05-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1765865, encodeId=f79b1e6586522, content=<a href='/topic/show?id=252ae1803a3' target=_blank style='color:#2F92EE;'>#白质#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71803, encryptionId=252ae1803a3, topicName=白质)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=778d36, createdName=柳叶一刀, createdTime=Tue Sep 21 08:14:29 CST 2021, time=2021-09-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1944703, encodeId=82921944e0309, content=<a href='/topic/show?id=411de6300ad' target=_blank style='color:#2F92EE;'>#粥样硬化#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=76300, encryptionId=411de6300ad, topicName=粥样硬化)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b30d401, createdName=huangshifeng, createdTime=Wed Apr 20 08:14:29 CST 2022, time=2022-04-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1950828, encodeId=a5511950828b8, content=<a href='/topic/show?id=20101021e97e' target=_blank style='color:#2F92EE;'>#高信号#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=102179, encryptionId=20101021e97e, topicName=高信号)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=08e4137, createdName=meichuangyi, createdTime=Tue Jul 20 09:14:29 CST 2021, time=2021-07-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1417576, encodeId=3900141e576f0, content=<a href='/topic/show?id=c667e181616' target=_blank style='color:#2F92EE;'>#白质高信号#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71816, encryptionId=c667e181616, topicName=白质高信号)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=44693296090, createdName=zhangph, createdTime=Sat May 22 10:14:29 CST 2021, time=2021-05-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1506829, encodeId=f1541506829fc, content=<a href='/topic/show?id=a1af849e063' target=_blank style='color:#2F92EE;'>#脑白质高信号#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=84970, encryptionId=a1af849e063, topicName=脑白质高信号)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=79949824561, createdName=rgjl, createdTime=Sat May 22 10:14:29 CST 2021, time=2021-05-22, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1222968, encodeId=b2561222968c8, content=<a href='/topic/show?id=98ba30898c7' target=_blank style='color:#2F92EE;'>#冠状动脉粥样硬化#</a>与<a href='/topic/show?id=7c4e84960c7' target=_blank style='color:#2F92EE;'>#脑白质#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=30898, encryptionId=98ba30898c7, topicName=冠状动脉粥样硬化), TopicDto(id=84960, encryptionId=7c4e84960c7, topicName=脑白质)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=清风徐来2022, createdTime=Sat May 28 11:36:30 CST 2022, time=2022-05-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1765865, encodeId=f79b1e6586522, content=<a href='/topic/show?id=252ae1803a3' target=_blank style='color:#2F92EE;'>#白质#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71803, encryptionId=252ae1803a3, topicName=白质)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=778d36, createdName=柳叶一刀, createdTime=Tue Sep 21 08:14:29 CST 2021, time=2021-09-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1944703, encodeId=82921944e0309, content=<a href='/topic/show?id=411de6300ad' target=_blank style='color:#2F92EE;'>#粥样硬化#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=76300, encryptionId=411de6300ad, topicName=粥样硬化)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b30d401, createdName=huangshifeng, createdTime=Wed Apr 20 08:14:29 CST 2022, time=2022-04-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1950828, encodeId=a5511950828b8, content=<a href='/topic/show?id=20101021e97e' target=_blank style='color:#2F92EE;'>#高信号#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=102179, encryptionId=20101021e97e, topicName=高信号)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=08e4137, createdName=meichuangyi, createdTime=Tue Jul 20 09:14:29 CST 2021, time=2021-07-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1417576, encodeId=3900141e576f0, content=<a href='/topic/show?id=c667e181616' target=_blank style='color:#2F92EE;'>#白质高信号#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71816, encryptionId=c667e181616, topicName=白质高信号)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=44693296090, createdName=zhangph, createdTime=Sat May 22 10:14:29 CST 2021, time=2021-05-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1506829, encodeId=f1541506829fc, content=<a href='/topic/show?id=a1af849e063' target=_blank style='color:#2F92EE;'>#脑白质高信号#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=84970, encryptionId=a1af849e063, topicName=脑白质高信号)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=79949824561, createdName=rgjl, createdTime=Sat May 22 10:14:29 CST 2021, time=2021-05-22, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1222968, encodeId=b2561222968c8, content=<a href='/topic/show?id=98ba30898c7' target=_blank style='color:#2F92EE;'>#冠状动脉粥样硬化#</a>与<a href='/topic/show?id=7c4e84960c7' target=_blank style='color:#2F92EE;'>#脑白质#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=30898, encryptionId=98ba30898c7, topicName=冠状动脉粥样硬化), TopicDto(id=84960, encryptionId=7c4e84960c7, topicName=脑白质)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=清风徐来2022, createdTime=Sat May 28 11:36:30 CST 2022, time=2022-05-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1765865, encodeId=f79b1e6586522, content=<a href='/topic/show?id=252ae1803a3' target=_blank style='color:#2F92EE;'>#白质#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71803, encryptionId=252ae1803a3, topicName=白质)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=778d36, createdName=柳叶一刀, createdTime=Tue Sep 21 08:14:29 CST 2021, time=2021-09-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1944703, encodeId=82921944e0309, content=<a href='/topic/show?id=411de6300ad' target=_blank style='color:#2F92EE;'>#粥样硬化#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=76300, encryptionId=411de6300ad, topicName=粥样硬化)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b30d401, createdName=huangshifeng, createdTime=Wed Apr 20 08:14:29 CST 2022, time=2022-04-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1950828, encodeId=a5511950828b8, content=<a href='/topic/show?id=20101021e97e' target=_blank style='color:#2F92EE;'>#高信号#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=102179, encryptionId=20101021e97e, topicName=高信号)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=08e4137, createdName=meichuangyi, createdTime=Tue Jul 20 09:14:29 CST 2021, time=2021-07-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1417576, encodeId=3900141e576f0, content=<a href='/topic/show?id=c667e181616' target=_blank style='color:#2F92EE;'>#白质高信号#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71816, encryptionId=c667e181616, topicName=白质高信号)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=44693296090, createdName=zhangph, createdTime=Sat May 22 10:14:29 CST 2021, time=2021-05-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1506829, encodeId=f1541506829fc, content=<a href='/topic/show?id=a1af849e063' target=_blank style='color:#2F92EE;'>#脑白质高信号#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=84970, encryptionId=a1af849e063, topicName=脑白质高信号)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=79949824561, createdName=rgjl, createdTime=Sat May 22 10:14:29 CST 2021, time=2021-05-22, status=1, ipAttribution=)]
  5. [GetPortalCommentsPageByObjectIdResponse(id=1222968, encodeId=b2561222968c8, content=<a href='/topic/show?id=98ba30898c7' target=_blank style='color:#2F92EE;'>#冠状动脉粥样硬化#</a>与<a href='/topic/show?id=7c4e84960c7' target=_blank style='color:#2F92EE;'>#脑白质#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=30898, encryptionId=98ba30898c7, topicName=冠状动脉粥样硬化), TopicDto(id=84960, encryptionId=7c4e84960c7, topicName=脑白质)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=清风徐来2022, createdTime=Sat May 28 11:36:30 CST 2022, time=2022-05-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1765865, encodeId=f79b1e6586522, content=<a href='/topic/show?id=252ae1803a3' target=_blank style='color:#2F92EE;'>#白质#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71803, encryptionId=252ae1803a3, topicName=白质)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=778d36, createdName=柳叶一刀, createdTime=Tue Sep 21 08:14:29 CST 2021, time=2021-09-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1944703, encodeId=82921944e0309, content=<a href='/topic/show?id=411de6300ad' target=_blank style='color:#2F92EE;'>#粥样硬化#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=76300, encryptionId=411de6300ad, topicName=粥样硬化)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b30d401, createdName=huangshifeng, createdTime=Wed Apr 20 08:14:29 CST 2022, time=2022-04-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1950828, encodeId=a5511950828b8, content=<a href='/topic/show?id=20101021e97e' target=_blank style='color:#2F92EE;'>#高信号#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=102179, encryptionId=20101021e97e, topicName=高信号)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=08e4137, createdName=meichuangyi, createdTime=Tue Jul 20 09:14:29 CST 2021, time=2021-07-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1417576, encodeId=3900141e576f0, content=<a href='/topic/show?id=c667e181616' target=_blank style='color:#2F92EE;'>#白质高信号#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71816, encryptionId=c667e181616, topicName=白质高信号)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=44693296090, createdName=zhangph, createdTime=Sat May 22 10:14:29 CST 2021, time=2021-05-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1506829, encodeId=f1541506829fc, content=<a href='/topic/show?id=a1af849e063' target=_blank style='color:#2F92EE;'>#脑白质高信号#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=84970, encryptionId=a1af849e063, topicName=脑白质高信号)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=79949824561, createdName=rgjl, createdTime=Sat May 22 10:14:29 CST 2021, time=2021-05-22, status=1, ipAttribution=)]
  6. [GetPortalCommentsPageByObjectIdResponse(id=1222968, encodeId=b2561222968c8, content=<a href='/topic/show?id=98ba30898c7' target=_blank style='color:#2F92EE;'>#冠状动脉粥样硬化#</a>与<a href='/topic/show?id=7c4e84960c7' target=_blank style='color:#2F92EE;'>#脑白质#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=30898, encryptionId=98ba30898c7, topicName=冠状动脉粥样硬化), TopicDto(id=84960, encryptionId=7c4e84960c7, topicName=脑白质)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=清风徐来2022, createdTime=Sat May 28 11:36:30 CST 2022, time=2022-05-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1765865, encodeId=f79b1e6586522, content=<a href='/topic/show?id=252ae1803a3' target=_blank style='color:#2F92EE;'>#白质#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71803, encryptionId=252ae1803a3, topicName=白质)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=778d36, createdName=柳叶一刀, createdTime=Tue Sep 21 08:14:29 CST 2021, time=2021-09-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1944703, encodeId=82921944e0309, content=<a href='/topic/show?id=411de6300ad' target=_blank style='color:#2F92EE;'>#粥样硬化#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=76300, encryptionId=411de6300ad, topicName=粥样硬化)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b30d401, createdName=huangshifeng, createdTime=Wed Apr 20 08:14:29 CST 2022, time=2022-04-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1950828, encodeId=a5511950828b8, content=<a href='/topic/show?id=20101021e97e' target=_blank style='color:#2F92EE;'>#高信号#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=102179, encryptionId=20101021e97e, topicName=高信号)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=08e4137, createdName=meichuangyi, createdTime=Tue Jul 20 09:14:29 CST 2021, time=2021-07-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1417576, encodeId=3900141e576f0, content=<a href='/topic/show?id=c667e181616' target=_blank style='color:#2F92EE;'>#白质高信号#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71816, encryptionId=c667e181616, topicName=白质高信号)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=44693296090, createdName=zhangph, createdTime=Sat May 22 10:14:29 CST 2021, time=2021-05-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1506829, encodeId=f1541506829fc, content=<a href='/topic/show?id=a1af849e063' target=_blank style='color:#2F92EE;'>#脑白质高信号#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=84970, encryptionId=a1af849e063, topicName=脑白质高信号)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=79949824561, createdName=rgjl, createdTime=Sat May 22 10:14:29 CST 2021, time=2021-05-22, status=1, ipAttribution=)]

相关资讯

真实世界研究表明:通络药物治疗心血管病现曙光

“3月17日,第十四届国际络病学大会在济南召开。上海长征医院吴宗贵教授、海军军医大学附属长征医院的梁春教授、中国医科大学附属第一医院曾定尹教授介绍了通络药物在真实世界中研究成果。

JACC:综述:抗血小板药治疗和预防冠状动脉粥样硬化

2017年10月,意大利、葡萄牙和英国等国科学家在《J Am Coll Cardiol》发表了抗血小板药治疗和预防冠状动脉粥样硬化的综述

Arthritis Rheumatol:生物制剂可以预防类风湿性关节炎的心血管事件

在类风湿性关节炎中,早期动脉粥样硬化患者使用bDMARD与CVD风险降低、非钙化病变的保护性钙化和新斑块形成的可能性降低相关。

Eur Radiol:如何利用冠状动脉钙化信息对急性肺栓塞进行风险评估?

导致右心室功能不全的因素之一是右心室缺血引起的心肌损伤。研究表明,有冠状动脉病史的急性PE患者与总死亡率升高相关。

ESC2015:稳定心绞痛患者踝肱指数与冠状动脉粥样硬化的严重性及特点的关系

5欧洲心脏病学会年会(ESC2015)专题报道 背景 踝肱指数(ABI)是一项无创的检查方法,可以评估下肢动脉是否通畅,也可筛查患者是否存在外周动脉疾病。有报道显示ABI降低与心血管死亡率相关。然而,ABI与冠状动脉疾病严重性的关系尚未充分阐明。 目的 本研究采用Gensini积分、iMap-IVUS及OCT评价稳定心绞痛患者踝肱指数与冠状动脉粥样硬化的严重性及特点的关系。

Circulation:冠状动脉疾病越严重,采用evolocumab治疗获益越大

近期,FOURIER试验(高风险患者应用PCSK9抑制剂的远期心血管预后研究)显示PCSK9抑制剂evolocumab可显著减少稳定型动脉粥样硬化血管疾病患者(包括既往发生过心肌梗死[MI]的患者)的主血管事件。研究人员推测在大量的有心肌梗死病史的患者中可能存在可鉴别应用evolocumab临床风险降低较明显的患者亚群的特征。研究人员根据最后一次心梗的时间、既往心梗的次数和是否存在多支参与冠脉病变